1.Clinical Characteristics of Autoimmune Disease with Dual Seropositive Antibodies of Leucine-rich Glioma Inactivated 1 and Contactin-associated Protein 2.
Li Ling DONG ; Hong Zhi GUAN ; Yan HUANG ; Hong Lin HAO ; Jing Wen NIU ; Qing LIU ; Qiang LU ; Dan XU ; Jun Yi ZHANG ; Li Xin ZHOU ; Li Ri JIN ; Hai Tao REN ; Yi Cheng ZHU ; Bin PENG ; Li Ying CUI ; Xiang Qin ZHOU
Acta Academiae Medicinae Sinicae 2019;41(3):344-350
Objective To explore the clinical characteristics of autoimmune disease with dual seropositive antibodies of leucine-rich glioma inactivated 1(LGI1)and contactin-associated protein 2(Caspr2).Methods The clinical data of seven patients with dual seropositive LGI1 and Caspr2 antibodies who were admitted to the Neurology Department of Peking Union Medical College Hospital from July 2014 to December 2017 were retrospectively analyzed.Results Central,peripheral and autonomic nervous systems were all involved in the seven cases;100%(7/7)presented with insomnia,myokymia,neuropahic pain and hyperhydrosis;71%(5/7)showed memory decline or psychiatric and behavioral symptoms;57%(4/7)had urinary hesitation or constipation;and 43%(3/7)had seizure.Electromyography showed 100%(6/6) of the patients had prolonged afterdischarges following normal M waves and/or abnormal spontaneous firing.Electroencephalography revealed slow waves or basic rhythm slowing in 71%(5/7)of patients.Electrocardiography showed sinus tachycardia,axis deviation,and prolonged QT intervals in 71%(5/7)of patients.One patient died from arrhythmia before immunotherapy.One died from pulmonary infection after immunotherapy.Improvement with immunotherapy was documented in the other five cases.No relapse was noted during the 1-2-year follow-up.Conclusions Autoimmune disease with dual seropositive antibodies of LGI1 and Caspr2 can diffusely affect the central,peripheral,and autonomic nervous systems.The possibility of this disease should be considered in patients with acute and subacute onset of neuropsychiatric symptoms,especially in patients with accompanying insomnia,myokymia,and hyperhydrosis.
Autoantibodies
;
blood
;
Autoimmune Diseases
;
immunology
;
Humans
;
Membrane Proteins
;
immunology
;
Nerve Tissue Proteins
;
immunology
;
Proteins
;
immunology
;
Retrospective Studies
2.Ionic Liquid Ultrasonic-assisted Solid Phase Extraction of Four Kinds of Hosenkosides from Seeds of Impatiens balsamina L.
Qian WU ; Hua LIN ; Ying LIU ; Yong-Ri JIN ; Peng LI ; Wei-Jie LIU ; Xu-Wen LI
Chinese Journal of Analytical Chemistry 2018;46(6):910-916
A green, rapid and efficient method was developed for the extraction of 4 kinds of hosenkosides from the seeds of Impatiens balsamina L. The hosenkosides were extracted by ionic liquid, and then enriched by solid phase extraction. The effects of the kinds and volume of ionic liquid, pH value, ultrasonic time, solid phase extractant and eluent on the extraction fields were investigated and optimized. Under the optimum conditions, the recoveries of 4 kinds of hosenkosides were between 92. 1% and 108. 2% , the correlation coefficients were 0. 9945-0. 9975, and the detection limits were 1. 8-4. 5 μg / mL. The RSD values were all less than 3. 9% . The experimental results showed that this method was fast, efficient, environmental protection. This study provided a reference for the extraction and enrichment of trace components in Chinese medicinal herbs.
3.Effect of the vacuum-formed retainer on preventing the proximal contact loss between implant supported crown and adjacent natural teeth.
Bai Jin ZENG ; Ying GUO ; Ri Yue YU
Journal of Peking University(Health Sciences) 2018;50(3):553-559
OBJECTIVE:
To evaluate the effect of the vacuum-formed retainer on preventing the proximal contact loss between the implant supported crown and its adjacent natural teeth.
METHODS:
Forty-six posterior implant crowns in the mandible including 92 interproximal contacts in 46 patients (19 men, 27 women) aged from 25 to 66 years were included. The participants in experimental group (22 cases) were vacuum-formed retainers at night, while participants in control group (24 cases) only received routine examination. The two groups were not different in age, gender, the time interval of the tooth loss and tooth position at baseline. Mesial and distal proximal contact tightness was measured using the orthodontic dynamometer and metallic articulating film immediately after crown delivery, and 1-month, 3-month, 6-month, and 1-year follow-up respectively. The articulating film was inserted interdentally from the occlusal direction, and then it was slowly removed in the buccallingual direction by the dynamometer. Increasing the number of films (N) piece by piece until the frictional force (F) was great than 0, and the number of films (N) was recorded. At each follow-up, proximal contact between implant crown and its adjacent teeth was considered to be loss if the number of films (N) used at immediate crown delivery passed without frictional force (F=0). Besides, the periodontal conditions [scored according to the probing depth (PD), bleeding index (BI), mobility (M)] and complaint of food impaction were recorded. The mesial and distal proximal contact loss rates were compared between the two groups at different times. Chi-square test or Fisher's exact test was used for statistical analysis.
RESULTS:
The proximal contact loss rate on the mesial surface of the implant supported crown continuously increased over the follow-up periods. At the end of the 1-, 3-, and 6-month follow ups, 18.2%, 22.7% and 27.3% were identified for the contact loss rates on the mesial surface of the implant supported crown in the experimental group, respectively. Meanwhile in control group, the rates were 20.8%, 37.5% and 45.8%. No significant differences were observed at the end of the 1-, 3-, and 6-month follow ups(1-month: χ2=0.000, P=1.000; 3-month: χ2=1.183, P=0.277; 6-month: χ2=1.697, P=0.193). The proximal contact loss rate on the mesial surface in control group (62.5%) was significantly higher than that in the experimental group (31.8%, χ2=4.330, P=0.037) at the end of the 1-year follow-up. However, no statistical difference was found on the distal surfaces between the two groups during the whole follow-up periods. The first open contact was noted 1 month after crown insertion.
CONCLUSION
By wearing vacuum-formed retainer for one year, the incidence of open contacts between the posterior implant prostheses and mesial adjacent teeth in the mandible has been reduced.
Crowns
;
Dental Implants, Single-Tooth
;
Dental Prosthesis, Implant-Supported
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Mandible
;
Mouth, Edentulous
;
Periodontal Diseases
;
Tooth
;
Tooth Loss
;
Vacuum
4.Clinical diagnosis and treatment of brucellosis disease
Ying XIE ; Zhi-Qin WU ; Hai-Guang XIN ; Wen-Sheng XU ; Rui-Ri JIN
Chinese Journal of Clinical Medicine 2016;23(4):505-507
Objective: To analyze and review the epidemiology , clinical features , treatment and prognosis of brucellosis ,in order to raise awareness of brucellosis in clinic .Methods:Eight clinical cases of brucellosis in Changzheng Hospital from 2010‐2015 were analyzed retrospectively ,and the clinical treatment experiences were concluded .Results:Five patients had history of epidemic exposure ,the epidemic exposure history of 3 cases were unknown .All patients had fever , fatigue and hyperhidrosis ,which 5 cases were accompanied by arthritis ,orchitis ,lymphadenectasis ,or migratory myalgia .The percentages of neutrophils in 8 cases were normal or relatively low ,and the erythrocyte sedimentation rate (ESR) was elevated in all patients ,in addition ,some indexes of liver function were elevated in 3 cases .All patients were cured by anti‐infective therapy , one patient who re‐contacted with goat was recrudescence .Conclusions: Brucellosis shows various clinical manifestations .Patients in non‐epidemic areas who have long‐term fever ,fatigue ,sweating or joint and muscle pain should be guarded against brucellosis ,and provide patients with early diagnosis and anti‐infective therapy .
5.Multivariate analysis of imatinib resistance-related factors during the treatment of chronic myeloid leukemia.
Min ZHOU ; Hui-ying QIU ; Guang-sheng HE ; Yang XU ; Jian-nong CEN ; Jin-lan PAN ; Su-ning CHEN ; Ai-ning SUN ; Ri ZHANG ; De-pei WU
Chinese Journal of Hematology 2013;34(5):395-398
OBJECTIVETo explore efficacy of imatinib for patients with chronic myeloid leukemia(CML) and its resistance-related factors during the treatment.
METHODSThe clinical data of 214 CML patients received imatinib were analyzed respectively in our hospital from April 2005 to December 2010. The therapy history and efficacy of regular follow-up and factors influencing drug resistance were analyzed. COX regression analysis was used to perform the univariate and multivariate analysis.
RESULTSUntil the end of follow up, thirty-one patients (14.5%) occurred drug resistance. One of them was in accelerated phase(AP), and two in blast phase(BP); 69.2% of patients achieved a complete cytogenetic response(CCyR), and 31.3% of patients achieved a major molecular response(MMR). COX analysis was performed in 207 chronic phase(CP) patients. Univariate analysis showed that the course of disease before treatment, the hemoglobin count, the white blood cell count, whether achieved CCyR or not and whether achieved MMR or not were the influencing factors for imatinib resistance. Multivariate analysis showed that whether achieved CCyR or not was the independent factor for drug resistance.
CONCLUSIONWhether achieved CCyR or not is an independent factor and also a protective factor for imatinib resistance in patients with CML.
Adolescent ; Adult ; Aged ; Benzamides ; therapeutic use ; Child ; Child, Preschool ; Drug Resistance, Neoplasm ; Female ; Follow-Up Studies ; Humans ; Imatinib Mesylate ; Leukemia, Myeloid, Chronic-Phase ; drug therapy ; Male ; Middle Aged ; Piperazines ; therapeutic use ; Pyrimidines ; therapeutic use ; Retrospective Studies ; Young Adult
6.Oral everolimus inhibits intimal proliferation in injured carotid artery in rats.
Xiao-Fang WANG ; De-Liang SHEN ; Xiao-Yan ZHAO ; Hong-Jie NING ; Ri-Sheng FENG ; Jin-Ying ZHANG
Chinese Medical Journal 2013;126(10):1906-1912
BACKGROUNDEverolimus, a derivative of sirolimus, is a potent immunosuppressant that has important anti-proliferative properties. In the present study, we demonstrated the inhibiting neointimal hyperplasia in injured carotid arteries in rats by using two different doses of everolimus administrated via the oral route for a long time.
METHODSA rat model of carotid artery injury was established by balloon inflation. Eighty rats were randomly divided into the sham-operated group (n = 20), injury group (n = 20), low dosage of everolimus group (n = 20), and high dosage of everolimus group (n = 20). The low dose of everolimus (1.5 mg/kg) was given one day before injuring the carotid artery by balloon, followed by 0.75 mg/kg per day for 28 days via intragastric gavage. High dose everolimus (2.5 mg/kg) was given one day before injuring the carotid artery by balloon, followed by 1 mg/kg per day for 28 days. Expression of eukaryotic translation initiation factor 4E (eIF-4E) and phosphorylation of ribosomal protein S6 kinase 1 (P70S6K) were determined by reverse transcription-polymerase chain reaction and Western blotting analysis.
RESULTSIn the injured carotid artery, neointimal hyperplasia was normally observed four weeks after injury. Everolimus inhibited neointimal hyperplasia after balloon injury in a dose dependent manner. At the same time, the study demonstrated that everolimus reduced the expression of P-P70S6K, eIF-4E, transforming growth factor (TGF)-β1 and of proliferating cell nuclear antigen (PCNA).
CONCLUSIONSEverolimus significantly inhibited neointimal hyperplasia of the injured carotid artery. The effect depended on dosage and was associated with the reduction of phosphorylation of P70S6K and the eIF-4E expression level.
Animals ; Carotid Arteries ; drug effects ; Carotid Artery Injuries ; drug therapy ; Carrier Proteins ; metabolism ; Everolimus ; Male ; Neointima ; drug therapy ; Phosphoproteins ; metabolism ; Phosphorylation ; drug effects ; Rats ; Rats, Sprague-Dawley ; Ribosomal Protein S6 Kinases, 70-kDa ; metabolism ; Sirolimus ; analogs & derivatives ; therapeutic use
7.Neurological adaptations to hypoxia in Tibetan antelope (Pantholops hodgsonii) with a view of molecular biology of respiratory globin-neuroglobin.
Zhen-Zhong BAI ; Ying-Zhong YANG ; Guo-En JIN ; Lan MA ; Ri-Li GE
Chinese Journal of Applied Physiology 2012;28(6):555-560
Neuroglobin (Ngb) is a respiratory protein that is preferentially expressed in brain of mouse and man. In this article, Tibetan antelope, living at altitude of 3 000-5 000 m for millions of years, was selected as the model of hypoxia-tolerant adaptation species. Using reverse transcription polymerase chain reaction (RT-PCR) and Western blot techniques, expression of Ngb gene was amplified and analyzed in antelope brain tissue. Our results showed that Ngb homology protein in Tibetan antelope was identified with more sequence similarity with cattle (96%), sheep (95%), and human (95%). We detected that there were some mutations occurred in the Open Reading Frame of Ngb in Tibetan antelope compared with sheep. Phylogenetic analysis of Ngb chain showed that it was closer to cattle than the others. This study suggests possible roles of central nervous system enriched Ngb in adaptation of Tibetan antelope to extremely high altitude.
Acclimatization
;
genetics
;
Altitude
;
Animals
;
Antelopes
;
genetics
;
Cattle
;
Globins
;
genetics
;
Humans
;
Hypoxia
;
genetics
;
Mice
;
Nerve Tissue Proteins
;
genetics
;
Phylogeny
;
Sheep
8.Chronic pharyngitis treated by garlic moxibustion.
Re-Hua CHEN ; Hao LIN ; Ri-Ying JIN
Chinese Acupuncture & Moxibustion 2012;32(1):58-58
Adolescent
;
Adult
;
Aged
;
Child
;
Female
;
Garlic
;
chemistry
;
Humans
;
Male
;
Middle Aged
;
Moxibustion
;
Pharyngitis
;
therapy
;
Young Adult
9.Anthocyanidin inhibits immunoglobulin E-mediated allergic response in mast cells.
Guang-Ri JIN ; Hai HONG ; Guang-Yu JIN ; Ying-Zhe LI ; Guang-Zhao LI ; Guang-Hai YAN
Acta Pharmaceutica Sinica 2012;47(1):34-38
This study is to investigate the anti-allergic effect of anthocyanidin and to explore its possible mechanism. The experiments of passive cutaneous anaphylaxis reaction (PCA) and colorimetry were used to determine the effect of anthocyanidin on degranulation of mast cells in vivo. For in vitro study, various concentrations of anthocyanidin (100, 50 and 25 micromol x L(-1)) were added to the culture medium of mast cells cultured with 100 microg x L(-1) of dinitrophenyl (DNP) specific IgE overnight. The azelastine (100 micromol x L(-1)) was selected as the positive control. The antigen (DNP-human serum albumin, DNP-HAS)-induced release of degranulation was measured by enzymatic assay, histamine was determined by EIA, and interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) were measured by Western blotting, separately. In addition, the effects of anthocyanidin on phosphorylation of NF-kappaB, p38MAPK and Akt were observed by Western blotting. The results showed that treatments with anthocyanidin (100 and 50 mg x kg(-1)) were followed by a decrease in PCA of rats. Anthocyanidin (100 and 50 micromol x L(-1)) obviously suppressed the degranulation from mast cells, whereas results from anthocyanidin (100 and 50 micromol x L(-1)) group indicated significant inhibitory effect on histamine, the calcium uptake, TNF-alpha, IL-6, phosphorylation of NF-kappaB, p38MAPK and Akt of mast cells induced by antigen. Anthocyanidin may suppress the anaphylactic reaction by inhibiting the action of mast cells. NF-kappaB, p38MAPK and Akt at least in part contribute to this event.
Animals
;
Anthocyanins
;
pharmacology
;
Anti-Allergic Agents
;
pharmacology
;
Calcium
;
metabolism
;
Cell Degranulation
;
drug effects
;
Histamine Release
;
drug effects
;
Immunoglobulin E
;
immunology
;
Interleukin-6
;
metabolism
;
Male
;
Mast Cells
;
immunology
;
metabolism
;
physiology
;
Passive Cutaneous Anaphylaxis
;
drug effects
;
Proto-Oncogene Proteins c-akt
;
metabolism
;
Random Allocation
;
Rats
;
Rats, Sprague-Dawley
;
Signal Transduction
;
Transcription Factor RelA
;
metabolism
;
Tumor Necrosis Factor-alpha
;
metabolism
;
p38 Mitogen-Activated Protein Kinases
;
metabolism
10.Acute T cells lymphoblastic leukemia with a t(1;19)(q23;p13) and E2A-PBX1 in an adult: one case report and literature review.
Guang-Sheng HE ; Xu-Hui ZHANG ; Li YAO ; Ri ZHANG ; Zi-Xing CHEN ; De-Pei WU ; Ai-Ning SUN ; Zheng-Ming JIN ; Hui-Ying QIU ; Xiao-Hui HU
Chinese Journal of Hematology 2009;30(10):675-677
OBJECTIVETo report a case of T cell acute lymphoblastic leukemia (ALL) with t(1;19)(q23;pl3) and E2A-PBX1 fusion gene, which is a characteristic translocation of childhood B cell ALL (B-ALL).
METHODSThe chromosome, karyotype, immunophenotype and mRNA for fusion gene of the leukemic cells were examined by cytogenetic analysis, flow cytometry (FCM) and reverse transcriptase PCR (RT-PCR), respectively.
RESULTSThe cytogenetic karyotype of the patient was 47, XY, 9p+, 15p+, 17q-, der(19), t(1;19)(q23;pl3)\[5\]/46, XY\[15\], and E2A-PBX1 was positive. The leukemic cells expressed T cell markers. The patient was induced with hyper CVAD regimen (cyclophosphamide, vincristine, adriamycin, and dexamethasone), and achieved complete remission with normal cytogenetic karyotype 46 XY\[10\], and negative E2A-PBX1.
CONCLUSIONt(1;19)E2A-PBX1(+) can be implicated in adult T-ALL, besides childhood B-ALL.
Adult ; Chromosomes, Human, Pair 1 ; genetics ; Chromosomes, Human, Pair 19 ; genetics ; Homeodomain Proteins ; genetics ; Humans ; Karyotyping ; Male ; Oncogene Proteins, Fusion ; genetics ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma ; drug therapy ; genetics ; Translocation, Genetic

Result Analysis
Print
Save
E-mail